Entourage Health Corp V.ENTG

Full Unedited Corporate Highlights from 2nd Quarter Report

[Wrywisdom]

• No edits whatsoever, and not a bit of negative news in the mix:
•  
• The Company announced the following appointments: Vaani Maharaj as CFO in April 2022; and Vincent Dor to Chief Legal Officer and Corporate Secretary in August 2022.
   
• In April 2022, Entourage announced the further upsizing of its existing credit facility with an affiliate of LiUNA Pension Fund of Central and Eastern Canada with an additional $15 million in funding availability and further upsized with an additional $8.9 million in June, 2022. This non-dilutive funding will be used for general working purposes to drive further commercial growth, and for repayment of the Company’s unsecured convertible debentures which matured on June 30, 2022.
   
• In May 2022, Entourage announced it had entered into an agreement with Pineapple Express – a wholly owned subsidiary of Fire & Flower Holdings Corp. – to launch same-day/next-day medical cannabis delivery services to the Company’s Starseed Medicinal patients.
   
• Also in May 2022, the Company entered into voting support agreements with certain holders of its 8.5% unsecured convertible debentures, and following debentureholders’ approval in June 2022, announced the subsequent implementation of the proposed amendments.
   
• Later in May, Entourage announced the Canadian debut of The Boston Beer Company’s (BBC) new cannabis-infused iced tea beverages ‘TeaPot’. Entourage is the exclusive distributor of TeaPot to local retailers in Canada. Launched in select provinces as of July 2022, TeaPot is the first non-alcoholic, infused beverage crafted in partnership with Boston Beer’s cannabis subsidiary BBCCC Inc., and Peak Processing, its bottling partner.
   
• At its annual general and special meeting of shareholders held in June 2022, shareholders overwhelmingly approved all proposed resolutions and director nominees including: George Scorsis, Gail Paech, Lu Cacioppo, Bruce Croxon and Jason Alexander with a combined 99.18% approval rating.
   
• In June 2022, the Company announced amendments to its senior secured and second secured credit facilities’ maturity dates, extending the terms respectively to June 30, 2024 and December 31, 2024.
   
• In July 2022, Entourage announced debentureholders approved certain amendments to the outstanding 9.0% unsecured convertible debentures of the Company’s subsidiary CannTx Life Sciences Inc.
   
• Later in July, Entourage announced the expansion of its medical offerings with the launch of new services, signing with HelloMD, a telehealth network to support high volume of patient consultations. The Company also debuted its customized, first-of-its-kind digital Patient Treatment Plan for registered patients looking for tailored products along with dosing guidelines.
   
• In August 2022, Entourage announced it entered into an exclusive licensing agreement with U.S.-based Irwin Naturals, a renowned nutraceuticals and herbal supplement formulator. Under the agreement, Entourage will produce and distribute Irwin Naturals Cannabis products in Canada. The first line of products are expected to be available to Starseed Medicinal patients in Q4 2022 with eventual expansion into adult-use retail stores. The strategic partnership follows recent release of recommendations for easing access to over-the-counter CBD products in Canadian pharmacies.